The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MK-6482, a hypoxia-inducible factor 2α inhibitor (HIF-2α), versus everolimus in heavily pretreated, immune checkpoint–inhibitor-resistant, advanced clear cell renal cell carcinoma (ccRCC): Phase III study.
 
Toni K. Choueiri
No Relationships to Disclose
 
Laurence Albiges
No Relationships to Disclose
 
Li Fan
No Relationships to Disclose
 
Rodolfo F. Perini
No Relationships to Disclose
 
Donna Vickery
No Relationships to Disclose
 
Thomas Powles
No Relationships to Disclose
 
Brian I. Rini
No Relationships to Disclose